Unknown

Dataset Information

0

MiR-134-5p Promotes Stage I Lung Adenocarcinoma Metastasis and Chemoresistance by Targeting DAB2.


ABSTRACT: Despite surgery and adjuvant therapy, early-stage lung adenocarcinoma (LUAD) treatment often fails due to local or metastatic recurrence. However, the mechanism is largely unknown. Here, we report that increased expression levels of miR-134-5p and decreased levels of disabled-2 (DAB2) were significantly correlated with recurrence in stage I LUAD patients. Our data show that miR-134-5p overexpression or DAB2 silencing strongly stimulated LUAD cell metastasis and chemoresistance. In contrast, inhibition of miR-134-5p or overexpression of DAB2 strongly suppressed LUAD cell metastasis and overcame the insensitivity of chemoresistant LUAD cells to chemotherapy. In addition, we demonstrated that DAB2 is a target of miR-134-5p and that miR-134-5p stimulates chemoresistance and metastasis through DAB2 in LUAD. Taken together, these findings suggest that miR-134-5p and its target gene DAB2 have potential as a biomarker for predicting recurrence in stage I LUAD patients. Additionally, miR-134-5p inhibition or DAB2 restoration may be a novel strategy for inhibiting LUAD metastasis and overcoming LUAD cell resistance to chemotherapy.

SUBMITTER: Zhang L 

PROVIDER: S-EPMC6838973 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6325824 | biostudies-other
| S-EPMC10851473 | biostudies-literature
| S-EPMC9287882 | biostudies-literature
| S-EPMC7202535 | biostudies-literature
| S-EPMC8554144 | biostudies-literature
| S-EPMC7335273 | biostudies-literature
2023-12-01 | GSE190461 | GEO
| S-EPMC7054484 | biostudies-literature
| S-EPMC7074368 | biostudies-literature
| S-EPMC8564129 | biostudies-literature